UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$948M |
| 2 |
Snowflake
SNOW
|
+$542M |
| 3 |
Sea Limited
SE
|
+$501M |
| 4 |
Procter & Gamble
PG
|
+$491M |
| 5 |
Snap
SNAP
|
+$403M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Infosys
INFY
|
+$434M |
| 2 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$350M |
| 3 |
Lowe's Companies
LOW
|
+$215M |
| 4 |
Applied Materials
AMAT
|
+$186M |
| 5 |
MXIM
Maxim Integrated Products
MXIM
|
+$183M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.21% |
| 2 | Healthcare | 13.25% |
| 3 | Financials | 13.07% |
| 4 | Consumer Discretionary | 12.28% |
| 5 | Communication Services | 10.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Repay Holdings
RPAY
$327M
| $1.34M | ﹤0.01% |
57,996
| – | – |
|
|
BLUE
1977
DELISTED
bluebird bio
BLUE
| $1.33M | ﹤0.01% |
5,381
+255
| +5% | +$72.9K |
|
|
AVNS
1978
DELISTED
Avanos Medical
AVNS
| $1.33M | ﹤0.01% |
42,614
-5,338
| -11% | -$181K |
|
1979
Cars.com
CARS
$660M
| $1.33M | ﹤0.01% |
105,081
+15,914
| +18% | +$201K |
|
1980
Seaboard Corp
SEB
$4.06B
| $1.33M | ﹤0.01% |
324
| – | – |
|
|
SWTX
1981
DELISTED
SpringWorks Therapeutics
SWTX
| $1.33M | ﹤0.01% |
20,913
| – | – |
|
1982
BioLife Solutions
BLFS
$1.7B
| $1.32M | ﹤0.01% |
31,116
-1,165
| -4% | -$56.1K |
|
1983
Alector
ALEC
$199M
| $1.32M | ﹤0.01% |
57,695
-3,344
| -5% | -$93.7K |
|
|
TUP
1984
DELISTED
Tupperware Brands Corporation
TUP
| $1.31M | ﹤0.01% |
62,239
+8,076
| +15% | +$181K |
|
1985
Atara Biotherapeutics
ATRA
$76.1M
| $1.31M | ﹤0.01% |
2,928
-516
| -15% | -$185K |
|
1986
Materion
MTRN
$6.04B
| $1.3M | ﹤0.01% |
18,905
+1,851
| +11% | +$132K |
|
|
DMC
1987
Del Monte Corp
DMC
$1.45B
| $1.29M | ﹤0.01% |
40,166
+6,139
| +18% | +$194K |
|
|
SPTN
1988
DELISTED
SpartanNash
SPTN
| $1.29M | ﹤0.01% |
59,064
+3,686
| +7% | +$74.1K |
|
|
GCP
1989
DELISTED
GCP Applied Technologies Inc.
GCP
| $1.29M | ﹤0.01% |
58,747
-2,390
| -4% | -$55.4K |
|
1990
V2X
VVX
$2.65B
| $1.28M | ﹤0.01% |
25,485
-1,360
| -5% | -$64.2K |
|
1991
TTM Technologies
TTMI
$14.5B
| $1.27M | ﹤0.01% |
101,396
+27,835
| +38% | +$383K |
|
|
VRTV
1992
DELISTED
VERITIV CORPORATION
VRTV
| $1.27M | ﹤0.01% |
14,221
+1,781
| +14% | +$136K |
|
1993
Coherus Oncology
CHRS
$196M
| $1.27M | ﹤0.01% |
78,911
| – | – |
|
1994
JFrog
FROG
$10.8B
| $1.26M | ﹤0.01% |
37,591
+7,275
| +24% | +$292K |
|
1995
NETGEAR
NTGR
$635M
| $1.26M | ﹤0.01% |
39,387
+6,742
| +21% | +$234K |
|
1996
The RealReal
REAL
$1.5B
| $1.26M | ﹤0.01% |
95,291
+11,098
| +13% | +$164K |
|
1997
Travere Therapeutics
TVTX
$5.78B
| $1.26M | ﹤0.01% |
51,775
-1,779
| -3% | -$32.7K |
|
1998
Bionano Genomics
BNGO
$13.3M
| $1.26M | ﹤0.01% |
380
+12
| +3% | +$42K |
|
1999
Parsons
PSN
$5.08B
| $1.25M | ﹤0.01% |
37,164
-18,965
| -34% | -$692K |
|
2000
Quanex
NX
$1.01B
| $1.25M | ﹤0.01% |
58,472
+5,567
| +11% | +$130K |
|
Similar funds
UBS AM's Q3 2021 Portfolio in Review
As of Q3 2021, UBS AM held 2,809 positions worth $241B, up 3.2% from $234B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
UBS AM deployed $8.13B of net new capital in Q3 2021, opening 56 new positions and adding to 1,358 existing holdings. Its largest new stake was State Street SPDR Portfolio Intermediate Term Treasury ETF: 6,053,315 shares worth $196M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Infosys, an estimated $434M trimmed.
- UBS AM's largest Q3 2021 buy was State Street SPDR Portfolio Intermediate Term Treasury ETF: 6,053,315 shares worth $196M.
- UBS AM added most to Microsoft in Q3 2021, an estimated $948M increase.
- UBS AM's biggest Q3 2021 reduction was Infosys, cutting an estimated $434M.
- UBS AM fully exited Vanguard Short-Term Treasury ETF in Q3 2021, selling an estimated $350M.
- UBS AM's ten largest holdings make up 22% of its $241B portfolio in Q3 2021.
- UBS AM opened 56 new positions and closed 62 in Q3 2021.
- UBS AM's portfolio value rose 3.2% quarter-over-quarter to $241B.
Based on UBS AM's 13F filing for Q3 2021, filed 15 Nov 2021.